drugset / Trial / NCT00482287
Pharmacokinetics and Pharmacodynamics of MTR105 in Hypotensive Cardiac Surgery Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety, pharmacokinetic and the pharmacodynamic effects of escalating doses of MTR105 while weaning from bypass in a hypotensive population of cardiac surgery patients.
Timeline
- Start
- 2008-01
- Primary completion
- 2008-06
- Completion
- 2008-06
Outcome
Outcome not reported
Stopped (Enrollment): “Site did not recruit any patients”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MTR105 | Unknown | 0.3 mg/kg | Intravenous |
| Subject | MTR105 | Unknown | 0.6 mg/kg | Intravenous |
| Subject | MTR105 | Unknown | 1.2 mg/kg | Intravenous |
| Subject | MTR105 | Unknown | 2.4 mg/kg | Intravenous |